NCT06036407 2026-04-14
HEAR
University of Bern
Phase NA Completed
Clinical Trials
26 trialsNCT06553157 2026-01-20
Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy
Minia University
Phase 1/2 Completed
NCT05789316 2026-01-12
Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)
Washington University School of Medicine
Phase NA Completed
NCT02425397 2025-12-01
OTOPLAT
Assistance Publique - Hôpitaux de Paris
Completed
NCT05936034 2025-11-28
PROTOTOX
Institut de Cancérologie de Lorraine
Phase NA Recruiting
NCT05756660 2025-10-20
Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy
Children's Hospital Medical Center, Cincinnati
Phase EARLY_PHASE1 Suspended
NCT06957132 2025-05-04
RISP-OTOTOX
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Not yet recruiting
NCT06551857 2025-04-16
CaSPiN
Turku University Hospital
Recruiting
NCT06929468 2025-04-16
Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer
Paracelsus Medical University
Not yet recruiting
NCT05641441 2025-01-13
Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma
University Hospital, Geneva
Recruiting
NCT03480971 2024-11-20
Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
Matrix Biomed, Inc.
Phase 2 Recruiting
NCT06490029 2024-07-08
BIO-OTOTOX
Direction Centrale du Service de Santé des Armées
Recruiting
NCT06297369 2024-03-07
Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients
Ain Shams University
Phase 2 Unknown
NCT00716976 2023-11-09
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
Children's Oncology Group
Phase 3 Completed
NCT05946577 2023-07-14
AURACCO
Assistance Publique - Hôpitaux de Paris
Not yet recruiting
NCT04262336 2023-07-06
Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment
Decibel Therapeutics
Phase 1 Completed
NCT02890030 2020-04-08
The Platinum Study Comparison Group
Indiana University
Completed
NCT01848457 2020-03-16
Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
Children's Hospital of Philadelphia
Phase 2 Completed
NCT00652132 2018-05-29
SIOPEL6
University of Birmingham
Phase 3 Completed
NCT03400709 2018-01-17
Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer
Hospital San Juan de Dios, Santiago
Phase NA Completed
NCT02382068 2017-11-09
Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin
Ohio State University Comprehensive Cancer Center
Phase NA Withdrawn
NCT01451853 2017-09-25
SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
Sound Pharmaceuticals, Incorporated
Phase 2 Unknown
NCT00458887 2017-03-13
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
Children's Oncology Group
Completed
NCT00477607 2014-03-07
Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin
VA Office of Research and Development
Phase 2/3 Completed
NCT00683319 2013-09-20
Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy
National Cancer Institute (NCI)
Active not recruiting
NCT01216800 2010-10-07
Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors
National Cancer Institute (NCI)
Phase 3 Unknown